Image-Guided Focused Ultrasound Gains Ground As Noninvasive Therapeutic Tool
Executive SummaryResearch into the use of image-guided focused ultrasound (IgFUS) as a noninvasive therapeutic modality is starting to achieve the kind of critical mass - in clinical outcomes data and R&D investment - necessary to win the interest and support of clinicians, payors, and regulators. Although there is still a good distance to travel before the technology achieves a routine place in the therapeutic toolkit, IgFUS is clearly an up-and-coming field in the medical device arena, and many believe it has the potential to revolutionize the treatment paradigm in a number of clinical areas.
You may also be interested in...
Medtronic is set for the U.S. launch of the Viva Quad XT and Viva Quad S cardiac resynchronization devices. Syncardia earns FDA approval for a new propriety valve set for its total artificial heart. Lombard earns Japanese approval for its AAA graft. Philips announces a unique case in Canada.